Cancer treatment and the ovary - The effects of chemotherapy and radiation

Division of Endocrinology, 300 Longwood Avenue, Boston, MA 02115, USA.
Annals of the New York Academy of Sciences (Impact Factor: 4.31). 07/2008; 1135:123-5. DOI: 10.1196/annals.1429.023
Source: PubMed

ABSTRACT Certain chemotherapeutic drugs ("alkylators") and radiation therapy are toxic to the ovaries, leading to both loss of sex steroid hormone production and infertility. Higher doses and older age at treatment are both associated with greater damage. Even patients with spontaneous menstrual cycles have evidence of decreased ovarian potential. Adolescents who are treated for cancer with these agents should be counseled about future fertility risks.

1 Follower
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Anti-NMDAR (N-methyl-D-aspartate receptor) encephalitis is an immune-mediated encephalitis. It has been predominantly described in young women and is commonly associated with an ovarian teratoma. We report a case of anti-NMDAR encephalitis associated with a 7 mm ovarian teratoma that was completely resected by laparoscopic surgery. An 18-year-old woman suddenly presented with personality changes requiring her admission to the department of neurology. After that, she also showed involuntary movements, disturbance of consciousness, and central hypoventilation. As an abdominal image revealed the possibility of a right ovarian teratoma of 5 × 7 mm, a laparoscopic operation was performed. The macroscopic appearance of the right ovary did not show any abnormalities; nevertheless, we performed a partial resection of the right ovary, with reference to the image diagnosis, in order to spare the ovarian reserve. The 22 × 22 mm partially resected ovary contained an intact 5 × 7 mm cystic tumor. The pathological diagnosis was mature cystic teratoma with components of brain tissue. An anti-NMDAR-antibody test proved positive in both serum and cerebrospinal fluid 1 month after the surgery. From these results, she was diagnosed with anti-NMDAR encephalitis. By the administration of cyclophosphamide in addition to the operation, she recovered drastically without any of the symptoms shown before.
    05/2014; 2014:618742. DOI:10.1155/2014/618742
  • [Show abstract] [Hide abstract]
    ABSTRACT: PURPOSEAs more young female patients with cancer survive their primary disease, concerns about reproductive health related to primary therapy gain relevance. Cancer therapy can often affect reproductive organs, leading to impaired pubertal development, hormonal regulation, fertility, and sexual function, affecting quality of life. METHODS The Children's Oncology Group Long-Term Follow-Up Guidelines for Survivors of Childhood, Adolescent, and Young Adult Cancer (COG-LTFU Guidelines) are evidence-based recommendations for screening and management of late effects of therapeutic exposures. The guidelines are updated every 2 years by a multidisciplinary panel based on current literature review and expert consensus.ResultsThis review summarizes the current task force recommendations for the assessment and management of female reproductive complications after treatment for childhood, adolescent, and young adult cancers. Experimental pretreatment as well as post-treatment fertility preservation strategies, including barriers and ethical considerations, which are not included in the COG-LTFU Guidelines, are also discussed. CONCLUSION Ongoing research will continue to inform COG-LTFU Guideline recommendations for follow-up care of female survivors of childhood cancer to improve their health and quality of life.
    Journal of Clinical Oncology 02/2013; 31(9). DOI:10.1200/JCO.2012.43.5511 · 17.88 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: La quimioterapia y la radioterapia provocan alteraciones irreversibles de la reserva y de la función ovárica que pueden dar lugar a una insuficiencia ovárica prematura en las mujeres adultas y jóvenes que padecen un cáncer. La radioterapia pélvica ocasiona también modificaciones morfológicas uterinas que también comprometen la fertilidad. La quimioterapia basada en agentes alquilantes, la intensificación terapéutica antes de un injerto de células madre hematopoyéticas y la radioterapia pélvica conllevan un alto riesgo de infertilidad. La congelación de embriones y la transposición ovárica son los únicos métodos reconocidos y establecidos de conservación de la fertilidad, aunque existen nuevas estrategias. La crioconservación de tejido ovárico con foliculogénesis in vivo mediante autoinjerto ortotópico o heterotópico es una alternativa prometedora y debe proponerse en la actualidad en caso de tratamiento muy gonadotóxico. Hasta el momento, se han descrito varias gestaciones obtenidas por esta técnica. Al contrario que la congelación embrionaria, la crioconservación de tejido ovárico tiene la ventaja de poder plantearse tanto en las mujeres jóvenes como las de edad prepuberal y además no requiere una estimulación previa que retrase el tratamiento. La protección farmacológica con análogos de la hormona liberadora de gonadotropinas (GnRH) también parece ser una alternativa útil. La foliculogénesis in vitro es una técnica experimental por el momento. Cuando se obtiene una gestación, los antecedentes de radioterapia son más perjudiciales que los de quimioterapia. La vigilancia obstétrica clásica debe asociarse a un protocolo para la detección de una recidiva o de otro cáncer. También conviene tranquilizar a la pareja ante los temores justificados que surgen por el riesgo mutágeno de los tratamientos antioncológicos.
    01/2010; 46(2):1–16. DOI:10.1016/S1283-081X(10)70771-2